Sometimes I wonder about this. I have personal experience that an ENT told nothing was wrong with the hearing of a person after tinnitus complaints following a loud explosion. He concluded that no damage was done after having checked the audiogram. (8kHz max.)
Also, I have read this many times here on the forum. People have tinnitus complaints and nothing is wrong according to a specialist (ENT).
But I do think you are correct when you say "we know what constitutes normal, healthy hearing".
I can understand that there needs to be much more than the standard 8kHz audiogram.
Especially after my own experience regarding this issue.
But that is a completely different discussion

I don't want to sound too negative. That is not how I feel about al the research that is happening at the moment.
I know, it seems crazy. The root of the problem comes down to the sociology of medicine. Tinnitus and hidden hearing loss fall at the intersection of neurology, otolaryngology, and audiology. It should be on all of their radars, but in fact it ends up on none. The pathology is not the result of a stroke/seizure (the focus of neurology), nor is there a medication or surgical option (the focus of ENT), nor can it be reliably corrected with a hearing aid (the focus of audiology).
The massive shortcomings of the audiogram for diagnosing hearing health is very well understood among hearing scientists. When I said "we", I was referring to researchers. I really feel your frustration when it comes to the audiologists and the ENT docs. A lot of the problems underlying hidden hearing loss and tinnitus are neural and most audiology/ENT training programs don't go beyond the hair cell so, in my experience, many (but not all) know less about these issues than a well-informed participant on this website. Of course, they don't know what they don't know and the clinical culture (at least in the US) places a premium on confidence and efficiency over deep thinking. If your doc doesn't go to international meetings or read the best journals otolaryngology or hearing research journals, chances are they are totally in the dark about this stuff.
I think the hearing research community will have to develop the tests for them. Mass. Eye and Ear just received a large award from the NIH this month to pursue this very issue. It will fund four laboratories (one project per laboratory) as they try to nail down new types of measurements that would shed light on the pathology underlying hearing in noise and tinnitus.
Project Number: 1P50DC015857-01A1
Contact PI / Project Leader: KUJAWA, SHARON G
Title: COCHLEAR SYNAPTOPATHY: PREVALENCE, DIAGNOSIS AND FUNCTIONAL CONSEQUENCES
Awardee Organization: MASSACHUSETTS EYE AND EAR INFIRMARY
Project Start Date: 2-AUG-2017
Project End Date: 31-JUL-2022
Cochlear synaptopathy is the loss of nerve connections between the sensory cells and the brain, which occurs in noise-damaged and aging ears. Although not detected by the threshold audiogram, this nerve damage is likely a major contributor to difficulties understanding speech in a noisy environment and may also instigate changes resulting in tinnitus and hyperacusis. Our Research Center aims to understand the prevalence of cochlear synaptopathy, measure/infer its consequences to suprathreshold sound processing, and to identify diagnostic markers. Therapies to reconnect nerves and sensory cells are on the horizon, and proper diagnostics are key to the design of clinical trials. The results are important to the public health, because noise- and ototoxic drug exposures may be damaging the ear well before the effects are seen in the threshold audiogram.
Abstract Text:
Overall Project Summary New insights from animal studies of noise-induced and age-related hearing loss suggest that the most vulnerable elements in the inner ear are the synaptic connections between hair cells and sensory neurons. This primary neural degeneration, also called cochlear synaptopathy, does not elevate thresholds. Thus, it can be widespread in ears with intact hair cell populations and normal audiograms, where it has been called "hidden" hearing loss. It likely contributes to difficulties understanding speech in a noisy environment and may be an instigating factor in the generation of tinnitus and hyperacusis. Cochlear synaptopathy may also be widespread in acquired sensorineural hearing loss of other etiologies and degrees of hair cell damage. Thus, it may be a major contributor to the well-known differences in auditory performance among people with identical audiometric patterns of "overt" hearing loss. Our Research Center aims to take these paradigm-shifting ideas from animal models to human subjects. Based on the synthesis of many research threads from the study of overt and hidden hearing loss, we have devised a set of physiological, electrophysiological and psychophysical tests of hearing and cochlear function that we believe are most powerful in the diagnosis and understanding of cochlear synaptopathy in human subjects. In Project 1, we apply this test battery to gerbils exposed to noise or ototoxic drugs and test their diagnostic power by directly measuring the underlying cochlear histopathology in cases of overt or hidden hearing loss. In Project 2, we use immunostaining to directly assess the prevalence of cochlear synaptopathy in human temporal bones from subjects with overt or hidden hearing loss with a range of etiologies. In Project 3, we study hidden hearing loss in college students by applying the test battery to subjects with normal audiograms but a broad range of reported and measured sound exposures. In Project 4, we assess older adults with overt hearing loss by applying the tests to a subject pool with carefully matched down-sloping audiograms and by characterizing training-based improvements in speech-in-noise performance as reflected at different peripheral, brainstem, midbrain and cortical levels. Our preliminary studies of young adults show clear signs of hidden hearing loss in a group with repeated exposure to high-level music, suggesting the importance of this phenomenon to the public health. The success of neurotrophin-based approaches to the treatment of cochlear synaptopathy in animal models suggests that therapies may be on the horizon. Thus, the need for better understanding of the prevalence, diagnosis and functional consequences of cochlear synaptopathy is clear.